Early Stage Venture BioShin Raises Series A of $60000000

September 27, 2020

About BioShin

BioShin is a clinical-stage biopharmaceutical company focused on developing medicines for the Asia-Pacific region.

Website: Learn more on BioShin’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – BioShin

Amount Raised60000000 USD
Announced Date2020-09-28
Equity Only FundingYes
Organization LocationShanghai, Shanghai, China, Asia
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsOrbiMed
Number of Investors5
Number of Partner Investors1
Previous Story

Early Stage Venture SISU Aesthetics Clinic Raises Series A of $5500000

Next Story

Early Stage Venture Adlumin, Inc Raises Series A of $6000000